In the mifepristone case, Kacsmaryk’s initial ruling was notable not just for its sweeping nature but in how he embraced the anti-abortion movement’s sensational rhetoric about the procedure. The groups fighting mifepristone argue that the Supreme Court’s decision shouldn’t affect the states’ ability to sue. Both the FDA and several medical groups, including the American Medical Association, told the Supreme Court that mifepristone is safe. But the Supreme Court knocked that argument aside, noting that federal law already allows doctors to avoid performing procedures that violate their conscience. Adam Unikowsky, a veteran Supreme Court litigator who has closely followed the mifepristone case, predicted it will be hard for the states to get the issue back before the Supreme Court.

---

Persons: Matthew Kacsmaryk, Donald Trump, ”, Carrie Flaxman, Brett Kavanaugh, mifepristone, ” Kavanaugh, Roe, Wade, Kansas –, Andrew Bailey, Kacsmaryk, Joe Biden’s, Biden, it’s, ” Julia Kaye, Erin Hawley, “, –, Adam Unikowsky, litigator, Unikowsky, They’re, ” Jaime Santos, Goodwin, “ that’s, Kavanaugh, isn’t Organizations: CNN, Trump, mifepristone, Supreme, Food, Democracy Forward, and Drug Administration, Republican, Alliance for Hippocratic, Biden, ACLU, Defending, FDA, American Medical Association Locations: Texas, Amarillo, – Missouri, Idaho, Kansas, Missouri, Texas ’, Mexico, Missouri , Idaho